The DOI matches its Crossref record.
Glucagon: Its Enhancement of Cardiac Performance in the Cat and Dog and Persistence of its Inotropic Action Despite Beta-Receptor Blockade with Propranolol
Open accessAbstract
The action of glucagon on cardiac performance was studied in 21 isolated cat papillary muscle preparations, in 13 spontaneously beating cat atria, in 15 intact dog hearts, and in 4 isolated perfused dog hindlimbs. In each papillary muscle preparation, addition of glucagon produced marked increases in maximal developed tension, averaging 36±4.2% ( SEM ) ( P < 0.01), and shifted the force-velocity curve upwards and to the right, indicating that contractility was augmented. Glucagon always increased the rate of the spontaneously beating atrium, the rise averaging 28.8±5.5 contractions/min ( P < 0.01). In the dog, myocardial performance was markedly augmented by the administration of glucagon, 50 µg/kg iv, as indicated by an average increase of 72.2±18.4% ( P < 0.01) in the left ventricular peak dP/dt and of 58.9±12.8% ( P < 0.01) in force recorded by a strain gauge arch, despite an average decrease of 3.8±1.2 cm H 2 O ( P < 0.02) in left ventricular end-diastolic pressure. Heart rate rose an average of 38.7±10.9 beats/min ( P < 0.02). Small but significant decreases in peripheral vascular resistance were produced. Single intravenous injections produced effects lasting 15 to 20 minutes. Propranolol did not prevent the inotropic responses in either the cat or dog preparations but markedly decreased the chronotropic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions
MAROKO, P. R., KJEKSHUS, J. K., SOBEL, B. E., WATANABE, T., COVELL, J. W., ROSS, J., & BRAUNWALD, E. (1971) · Circulation · doi:10.1161/01.cir.43.1.67 · Cited by 1,486
The New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
Cardiovascular effects of glucagon in man
Parmley, W. W., Glick, G., & Sonnenblick, E. H. (1968) · New England Journal of Medicine · doi:10.1056/nejm196807042790103 · Cited by 246
Self-citationAnti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
Hemodynamic Effects of Glucagon: A Literature Review
Petersen, K. M., Bøgevig, S., Holst, J. J., Knop, F. K., & Christensen, M. B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00050 · Cited by 68
Metadata
- Authors
- GLICK, G., PARMLEY, W. W., WECHSLER, A. S., SONNENBLICK, E. H., Lewis, R. M., & McGill, R. D.
- Venue
- Circulation Research
- Published
- 1968-06
- Volume
- 22
- Issue
- 6
- Pages
- 789-799
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2085064806
- Cited by
- 248
- References
- 0
- FWCI
- 49.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucagon: Its Enhancement of Cardiac Performance in the Cat and Dog and Persistence of its Inotropic Action Despite Beta-Receptor Blockade with Propranolol. https://app.cochat.ai/papers/10.1161/01.res.22.6.789
- The paper
- GLICK, G., PARMLEY, W. W., WECHSLER, A. S., SONNENBLICK, E. H., Lewis, R. M., & McGill, R. D. (1968). Glucagon: Its Enhancement of Cardiac Performance in the Cat and Dog and Persistence of its Inotropic Action Despite Beta-Receptor Blockade with Propranolol. Circulation Research. https://doi.org/10.1161/01.res.22.6.789
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.